# Provista Diagnostics Inc.: Form D filings

Provista Diagnostics Inc., a biotechnology company in Scottsdale, AZ, filed 10 Form D notices with the SEC between 2012 and 2018. The latest, on May 22, 2018, reports $2.2 million sold of a $5 million offering to 6 investors.

Find out what Provista Diagnostics Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Provista%20Diagnostics%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Provista%20Diagnostics%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fprovista-diagnostics-inc-1539252)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Provista%20Diagnostics%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Provista%20Diagnostics%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fprovista-diagnostics-inc-1539252)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Arizona](https://specstream.ai/data/form-d/state/arizona): 953 rows, by operating companies, filed since November 1, 2024, $47.65, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/arizona
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 17301 N. PERIMETER DRIVE, SUITE 100, Scottsdale, AZ, 85255
- Phone: (602) 224-5500
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1539252

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 22, 2018 | New notice | $5,000,000 | $2,205,633 | $2,794,367 | 6 | May 17, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1539252/000173941418000003/0001739414-18-000003-index.htm) |
| Sep 15, 2017 | New notice | $4,000,000 | $2,331,084 | $1,668,916 | 28 | Jul 26, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1539252/000143953917000004/0001439539-17-000004-index.htm) |
| Oct 26, 2016 | New notice | $6,000,000 | $2,564,948 | $3,435,052 | 5 | Oct 13, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1539252/000153925216000004/0001539252-16-000004-index.htm) |
| Mar 18, 2016 | New notice | $5,100,990 | $5,100,990 | $0 | 25 | Mar 8, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1539252/000153925216000003/0001539252-16-000003-index.htm) |
| Aug 3, 2015 | New notice | $6,046,254 | $6,046,254 | $0 | 27 | Jul 23, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1539252/000153925215000002/0001539252-15-000002-index.htm) |
| Mar 16, 2015 | New notice | $3,870,986 | $3,870,986 | $0 | 24 | Feb 17, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1539252/000153925215000001/0001539252-15-000001-index.htm) |
| Apr 17, 2014 | New notice | $6,000,000 | $6,000,000 | $0 | 34 | Apr 8, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1539252/000153925214000001/0001539252-14-000001-index.htm) |
| Apr 24, 2013 | New notice | $6,000,000 | $5,999,999 | $1 | 35 | Apr 10, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1539252/000153925213000003/0001539252-13-000003-index.htm) |
| Sep 21, 2012 | Amendment | $7,485,891 | $7,485,891 | $0 | 32 | Feb 17, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1539252/000153925212000006/0001539252-12-000006-index.htm) |
| Mar 1, 2012 | New notice | $4,950,000 | $4,510,000 | $440,000 | 18 | Feb 17, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1539252/000153925212000005/0001539252-12-000005-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Jack J. Levine | Director |  |
| John G. Fermanis | Executive Officer |  |
| John J. Macaskill | Director |  |
| Cynthia E. Collins | Director |  |
| John G. Zicarelli | Director |  |
| Rao G. Mulpuri | Executive Officer |  |
| Robert J. Hariri | Director |  |
| Thomas G. Mendell | Director |  |
| Gary Altman | Executive Officer, Director |  |
| Jeffrey R. Gilman | Director |  |
| Yoji G. Nimura | Director |  |
| Uriel E. Kusiatin | Executive Officer |  |

## Other biotechnology companies in Arizona that filed recently

- [Gut-Brain-Axis Therapeutics Inc.](https://specstream.ai/data/form-d/company/gut-brain-axis-therapeutics-inc-1996678) $2 million · Oct 27, 2026
- [Avery Therapeutics, Inc.](https://specstream.ai/data/form-d/company/avery-therapeutics-inc-1708135) $8.5 million · Sep 21, 2026

[Every Form D from the week of May 21, 2018](https://specstream.ai/data/form-d/week/2018-05-21) · [All recent filings in Arizona](https://specstream.ai/data/form-d/state/arizona) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Provista Diagnostics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).